These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 10964337
21. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases. Blom R, Guerrieri C, Stâl O, Malmström H, Sullivan S, Simonsen E. Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654 [Abstract] [Full Text] [Related]
22. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Sinicrope FA, Hart J, Michelassi F, Lee JJ. Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900 [Abstract] [Full Text] [Related]
23. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy. Abaza R, Diaz LK, Laskin WB, Pins MR. J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199 [Abstract] [Full Text] [Related]
24. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma. Dalquen P, Moch H, Feichter G, Lehmann M, Solèr M, Stulz P, Jordan P, Torhorst J, Mihatsch MJ, Sauter G. Virchows Arch; 1997 Sep; 431(3):173-9. PubMed ID: 9334838 [Abstract] [Full Text] [Related]
25. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA, El-Emshaty HM, Tabll A, Elmasry SA, Attallah AM, Gad Elhak NA. Hepatogastroenterology; 2004 Sep; 51(58):1001-6. PubMed ID: 15239234 [Abstract] [Full Text] [Related]
26. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA. J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [Abstract] [Full Text] [Related]
27. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma. Skirnisdóttir I, Sorbe B, Karlsson M, Seidal T. Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603 [Abstract] [Full Text] [Related]
30. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2. Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G, Mottolese M. Int J Cancer; 1999 Dec 22; 84(6):545-52. PubMed ID: 10567896 [Abstract] [Full Text] [Related]
31. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL. APMIS Suppl; 2003 Dec 22; (108):1-67. PubMed ID: 12874968 [Abstract] [Full Text] [Related]
32. Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. Santinelli A, Ranaldi R, Baccarini M, Mannello B, Bearzi I. Pathol Res Pract; 1999 Dec 22; 195(7):467-74. PubMed ID: 10448663 [Abstract] [Full Text] [Related]
38. [Flow cytometry-pathology combined study of breast cancer]. Yu ZY, Yu JM, Wu TH, Zhuo PY, Wang SF, Li M, Zhang X, Lü BY, Liu YB. Zhonghua Zhong Liu Za Zhi; 2005 Jul 22; 27(7):420-2. PubMed ID: 16188128 [Abstract] [Full Text] [Related]
39. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma. Yu DS, Wang J, Chang SY, Ma CP. Eur Urol; 1991 Jul 22; 20(3):227-31. PubMed ID: 1823046 [Abstract] [Full Text] [Related]